Skip to content
Lower risk Medical device recall · FDA · Published October 31, 2025

Philips Lumify Diagnostic Ultrasound System: iOS 18 Compatibility Issues May Cause Imaging

Philips recalls Lumify Diagnostic Ultrasound System models 795005, 795161, 989605449841 for potential imaging failures when used with Apple iOS 18. Affected units may not perform live imaging properly. No remedy specified in recall.

🇺🇸 FDA recall #Z-0883-2026Medical devicePhilips ›
Take action

Contact the company

Recalling firmPhilips Ultrasound, LLC22100 Bothell Everett Hwy · Bothell, WA 98021-8431
✎ GovInfoNow plain-language explainer

Philips is recalling specific Lumify Diagnostic Ultrasound System models that may not perform live imaging properly when used with Apple iOS 18. This could affect medical imaging accuracy during use. No action is required by the manufacturer as of the recall announcement. Read more at govinfonow.com/recall/50832-philips-lumify-diagnostic-ultrasound-system-ios-18-compatibility-issues-may.

Source Summary by GovInfoNow · govinfonow.com/recall/50832-philips-lumify-diagnostic-ultrasound-system-ios-18-compatibility-issues-may · Updated August 18, 2026 · FDA enforcement record: FDA #Z-0883-2026

Cite this page

“Philips Lumify Diagnostic Ultrasound System: iOS 18 Compatibility Issues May Cause Imaging.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/50832-philips-lumify-diagnostic-ultrasound-system-ios-18-compatibility-issues-may. Based on FDA recall #Z-0883-2026 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0883-2026%22&limit=1).

The U.S. Food and Drug Administration (FDA) has issued a voluntary recall for certain Philips EPIQ Elite Ultrasound Systems due to a software error that may result in inaccurate blood flow measurements, posing a risk of misdiagnosis.

How to tell if you have it

  • Philips EPIQ Elite Ultrasound System
  • Class II medical device
  • Voluntary recall initiated by Philips Ultrasound, LLC

The hazard

Due to a software issue, the Doppler sample volume is displayed shallower than its actual measurement location on the ultrasound image. This discrepancy can lead to inaccurate blood flow velocity measurements, which may result in misdiagnosis or inappropriate clinical decisions regarding patient care.

Context

This recall follows previous safety notices from Philips Ultrasound, LLC, including a 2026 recall for similar EPIQ Elite systems regarding the same hazard. In 2022, Philips issued a separate recall for Philips EPIQ Ultrasound Systems with X5-1c Transducers due to unexpected reboots that could damage the transducer. Recent related recalls include software issues in Philips Azurion Systems (December 2025) and sensor instability in Philips Incisive CT scanners (December 2025), highlighting ongoing quality control challenges within the manufacturer's product line.

How to tell if you have this one

Check your Lumify Diagnostic Ultrasound System model numbers: 795005, 795161, or 989605449841. Also verify your serial numbers against the list provided in the recall notice.

  • Brand
    Philips
  • Category
    Medical device
Based on the official FDA remedy

What to do — step by step

  1. Check Model Numbers

    Review your product's model numbers to see if they match the recalled models: 795005, 795161, or 989605449841.

Where it went and when

Where it was distributed

Distributed nationwide and abroad; the notice names 47 states.

Alaska: nationwideAKMaine: named in the noticeMEVermont: named in the noticeVTNew Hampshire: named in the noticeNHWashington: named in the noticeWAIdaho: named in the noticeIDMontana: named in the noticeMTNorth Dakota: nationwideNDMinnesota: named in the noticeMNIllinois: named in the noticeILWisconsin: named in the noticeWIMichigan: named in the noticeMINew York: named in the noticeNYRhode Island: named in the noticeRIMassachusetts: named in the noticeMAOregon: named in the noticeORNevada: named in the noticeNVWyoming: named in the noticeWYSouth Dakota: named in the noticeSDIowa: named in the noticeIAIndiana: named in the noticeINOhio: named in the noticeOHPennsylvania: named in the noticePANew Jersey: named in the noticeNJConnecticut: named in the noticeCTCalifornia: named in the noticeCAUtah: named in the noticeUTColorado: named in the noticeCONebraska: named in the noticeNEMissouri: named in the noticeMOKentucky: named in the noticeKYWest Virginia: named in the noticeWVVirginia: named in the noticeVAMaryland: named in the noticeMDDelaware: named in the noticeDEArizona: named in the noticeAZNew Mexico: named in the noticeNMKansas: nationwideKSArkansas: named in the noticeARTennessee: named in the noticeTNNorth Carolina: named in the noticeNCSouth Carolina: named in the noticeSCDistrict of Columbia: named in the noticeDCOklahoma: named in the noticeOKLouisiana: named in the noticeLAMississippi: named in the noticeMSAlabama: named in the noticeALGeorgia: named in the noticeGAHawaii: named in the noticeHITexas: named in the noticeTXFlorida: named in the noticeFLPuerto Rico: named in the noticePR

FDA distribution: “Worldwide US Nationwide distribution including in the states of AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, PR, RI, SC, SD, TN, TX, UT, VA,…” States read from FDA’s own wording; “not listed” means the notice does not name it.

Named in the notice: Alabama, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, District of Columbia, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, Puerto Rico, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, Wisconsin, Wyoming.

Recall timeline

FDA published this recall 40 days after the firm started it.

1. Firm started the recall: Oct 31, 202512. FDA classified it Class II: Dec 4, 202523. Published in FDA’s Enforcement Report: Dec 10, 202532025
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-0883-2026 (October 31, 2025) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-0883-2026 to see it in context.
  • Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA